EUVIMEDEUVIMED entdecken
Crossref

Clinical significance and potential mechanism of AEBP1 in glioblastoma

Chengcheng Wang, Huan Han, Fang Cheng, Hao Wang, Junlong Wang, Chong Lv, Shibin Jiang, Yan Peng, Xiaoling Zhao iD

Journal of Neuropathology & Experimental Neurology · 2024

DOI: 10.1093/jnen/nlae091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, 2024. Verfasst von Chengcheng Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Xingtai People's Hospital, Xingtai, China. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastomas (GBM), the most common primary brain tumor, lack accurate prognostic markers and have a poor prognosis. Our study was designed to identify effective biomarkers for GBM prognosis analysis and development of precise treatments. Differentially expressed genes (DEGs) between GBM patients and controls were analyzed from the Xena database and GEPIA. Based on the screened DEGs, univariate COX and LASSO regression analysis were performed to identify the most relevant genes associated with GBM prognosis. Genes highly expressed in GBM patients were selected to construct receiver operating characteristic analysis and enrichment analysis was constructed on groups of high and low expression of adipocyte enhancer-binding protein 1 (AEBP1). CIBERSORT, ssGSEA and ESTIMATE were used to perform immune infiltration analysis. About 3297 DEGs were identified using data from Xena database; 8 prognostic genes were identified. AEBP1, which plays a role in neuronal differentiation and development, was positively correlated in GBMs with immune infiltration; its high expression in cancer patients is associated with short overall survival and advanced tumor staging. This study suggests that AEBP1 could serve as a prognostic marker for GBMs and that patients with high expression may have a better response to immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsBiomarkers, TumorHumansPrognosisGene Expression Regulation, NeoplasticMaleFemaleClinical RelevanceCarboxypeptidasesRepressor Proteins

Stichwörter der Autor:innen

AEBP1glioblastomaimmune infiltrationprognostic biomarker

Substanzen

AEBP1 protein, humanBiomarkers, TumorCarboxypeptidasesRepressor Proteins

Autor:innen und Institutionen

  • Department of Dermatology, Xingtai People's Hospital, Xingtai, China.
  • Department of Hematology, Xingtai People's Hospital, Xingtai, China.
  • Department of Neurosurgery, Xingtai People's Hospital, Xingtai, China.
  • Department of Dermatology, Shahe City People's Hospital, Xingtai, China.
  • Department of Oncology, Xingtai People's Hospital, Xingtai, China.

ORCID-Profile: Xiaoling Zhao

Zitieren

APA

Wang, C., Han, H., Cheng, F., Wang, H., Wang, J., Lv, C., Jiang, S., Peng, Y., & Zhao, X. (2024). Clinical significance and potential mechanism of AEBP1 in glioblastoma. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlae091

Vancouver

Wang C, Han H, Cheng F, Wang H, Wang J, Lv C, et al. Clinical significance and potential mechanism of AEBP1 in glioblastoma. Journal of Neuropathology & Experimental Neurology. 2024. doi:10.1093/jnen/nlae091

BibTeX
@article{Wang2024,
  author = {Wang, Chengcheng and Han, Huan and Cheng, Fang and Wang, Hao and Wang, Junlong and Lv, Chong and Jiang, Shibin and Peng, Yan and Zhao, Xiaoling},
  title = {Clinical significance and potential mechanism of AEBP1 in glioblastoma},
  journal = {Journal of Neuropathology & Experimental Neurology},
  year = {2024},
  doi = {10.1093/jnen/nlae091}
}
Kostenlos starten →